Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
According to Co-Diagnostics, Inc.'s latest financial reports the company's current revenue (TTM) is $6.81 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
---|---|---|---|---|---|
2023 | $6.81 M | $2.63 M | $-41,475,760 | $-38,110,556 | $-35,332,865 |
2022 | $34.22 M | $28.74 M | $-10,308,573 | $-18,847,234 | $-14,238,249 |
2021 | $97.89 M | $86.31 M | $46.4 M | $45.64 M | $36.66 M |
2020 | $74.55 M | $57.96 M | $41.83 M | $42.57 M | $42.48 M |
2019 | $214.97 K | $102.54 K | $-6,023,218 | $-6,195,557 | $-6,069,113 |
2018 | $39.91 K | $30.52 K | $-6,086,011 | $-6,271,723 | $-6,271,723 |
2017 | $7.66 K | $7.36 K | $-6,602,939 | $-6,959,232 | $-6,959,232 |
2016 | $ | $-37,491 | $-1,650,475 | $-1,928,686 | $-1,928,686 |
2015 | $10 K | $-33,140 | $-1,924,839 | $-2,043,168 | $-2,043,168 |
2014 | $ | $ | $-1,020,777 | $-1,048,124 | $-1,048,124 |